Clinical Trial Update: A Randomized Double Dummy Double Blind Dose Determining Place-bo Controlled Study to Evaluate Efficacy of Investigational Product E-RH-06 at 2 Dose Levels for the Metabolic Management of Chronic or Recurrent, Non-infective Nasal Congestion With-or-without Rhinorrhea. [NA]

View source ↗

Summary

A randomized, double-dummy, double-blind dose-finding trial is planned to assess the efficacy of the investigational product E-RH-06 at two dose levels for chro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinitis

Drugs mentioned

• E-RH-06

Snippet

Sponsor: Enovate Biolife Pvt Ltd | Conditions: Chronic Rhinitis | NA | Status: UNKNOWN